glp-1 analogues list of agonists current and its analogs [36-39] Glucagon-Like Peptide 1 Receptor Agonists – GLP-1 drugs are showing potential

Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes

But in 2016, the LEADER trial revealed a new dimension: fewer cardiovascular events in patients with type 2 diabetes

Your program may include: GLP-1 medication therapy Lifestyle coaching Nutritional guidance Body composition analysis Supportive therapies for energy, metabolism, and wellness

Just peel and stick

Several trials have found that it moderately improves blood glucose levels and can help patients lose up to 5 kgs (about 11 pounds) in 6 months

Clin Ther 29(1):139153 Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH et al (2009) Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)